Table 2.

Relationship between MRPL13 expression and clinicopathological parameters of ovarian epithelial malignant tumors.

Groups	Cases	Low		High		Positive rate (%)	P value	High positive rate (%)	P value
		-	+	++	+++
Age							0.439		0.754
<55	58	5	11	17	25	91.38		72.41
≥55	56	2	12	23	19	96.43		75.00
FIGO stage							0.431		0.025*
I-II	45	4	13	15	13	91.11		62.22
III-IV	69	3	10	25	31	95.65		81.16
Differentiation							0.714		0.336
Well-moderate	56	4	13	17	22	92.86		69.64
Poor	58	3	10	23	22	94.83		77.59
Lymphatic metastasis							0.350		0.815
No	72	3	16	26	27	95.83		73.61
Yes	29	3	4	11	11	89.66		75.86
Unknown	13	1	3	3	6	92.31		69.23
Pathological type							0.723		0.239
Serous	71	5	13	30	23	92.96		74.65
Mucinous	10	0	4	2	4	100.00		60.00
Endometrioid	20	2	5	5	8	90.00		65.00
Clear cell carcinoma	13	0	1	3	9	100.00		92.31